Recommendations for the care of patients with cardiovascular disease in health emergency situations: a call to action

References

• Task Force for the Management of COVID-19 of the European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. Eur Heart J. 2022;43:1033–1058.
   PubMed Web of Science ®Google Scholar
• CAPACITY-COVID Collaborative Consortium and LEOSS Study Group. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries. Eur Heart J. 2022;43(11):1104–1120.
   PubMed Web of Science ®Google Scholar
• Lechner I, Reindl M, Tiller C, et al. Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study. Eur Heart J. 2022;43(11):1141–1153.
   PubMed Web of Science ®Google Scholar
• Martinez-Ferran M, de la Guía-Galipienso F, Sanchis-Gomar F, et al. Metabolic impacts of confinement during the COVID-19 pandemic due to modified diet and physical activity habits. Nutrients. 2020;12(6):1549.
   PubMed Web of Science ®Google Scholar
• Mattioli AV, Sciomer S, Cocchi C, et al. Quarantine during COVID-19 outbreak: changes in diet and physical activity increase the risk of cardiovascular disease. Nutr Metab Cardiovasc Dis. 2020;30(9):1409–1417.
   PubMed Web of Science ®Google Scholar
• Mattioli AV, Ballerini Puviani M, Nasi M, et al. COVID-19 pandemic: the effects of quarantine on cardiovascular risk. Eur J Clin Nutr. 2020;74(6):852–855.
   PubMed Web of Science ®Google Scholar
• Fisher A, Roberts A, McKinlay AR, et al. The impact of the COVID-19 pandemic on mental health and well-being of people living with a long-term physical health condition: a qualitative study. BMC Public Health. 2021;21(1):1801.
   PubMed Web of Science ®Google Scholar
• Abbasi J. The COVID heart-one year after SARS-CoV-2 infection, patients have an array of increased cardiovascular risks. J Am Med Assoc. 2022;327(12):1113–1114.
   Web of Science ®Google Scholar
• Elseidy SA, Awad AK, Vorla M, et al. Cardiovascular complications in the post-acute COVID-19 syndrome (PACS). Int J Cardiol Heart Vasc. 2022;40:101012.
   PubMed Web of Science ®Google Scholar
• Raman B, Bluemke DA, Lüscher TF, et al. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157–1172.
   PubMed Web of Science ®Google Scholar
• , Ferat LR, Forrest R, Global Coalition for Circulatory Health, et al. Preventing the next pandemic: the case for investing in circulatory health - a global coalition for circulatory health position paper. Glob Heart. 2021;16:66.
   PubMed Web of Science ®Google Scholar
• Gerotziafas GT, Catalano M, Theodorou Y, et al. The COVID-19 pandemic and the need for an integrated and equitable approach: an international expert consensus paper. Thromb Haemost. 2021;121(8):992–1007.
   PubMed Web of Science ®Google Scholar
• Gil Membrado C, Barrios V, Cosín-Sales J, et al. Telemedicina, ética y derecho en tiempos de COVID-19. Una mirada hacia el futuro. Rev Clin Esp. 2021;221(7):408–410.
   Web of Science ®Google Scholar
• Silva-Cardoso J, Juanatey González JR, Comin-Colet J, et al. The future of telemedicine in the management of heart failure patients. Card Fail Rev. 2021;7:e11.
   PubMedGoogle Scholar
• Barrios V, Cosín-Sales J, Bravo M, et al. La consulta telemática Para el cardiólogo clínico en tiempos de la COVID-19: presente y futuro. Rev Esp Cardiol. 2020;73(11):910–918.
   Web of Science ®Google Scholar
• Hollowell A, Swartz J, Myers E, et al. Telemedicine services in higher education: a review of college and university websites. J Am Coll Health. 2022 [cited Mar 17]; 1–6.
   PubMed Web of Science ®Google Scholar
• Eberly LA, Khatana SAM, Nathan AS, et al. Telemedicine outpatient cardiovascular care during the COVID-19 pandemic: bridging or opening the digital divide? Circulation. 2020;142(5):510–512.
   PubMed Web of Science ®Google Scholar
• Gijón-Conde T, Rubio E, Gorostidi M, et al. Documento de consenso sobre consulta telemática en hipertensión y riesgo vascular. Sociedad Española de Hipertensión-Liga Española Para la Lucha contra la Hipertensión Arterial (SEH-LELHA). Hipertens Riesgo Vasc. 2021;38(4):186–196.
   PubMedGoogle Scholar
• Omboni S, Padwal RS, Alessa T, et al. The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connect Health. 2022;1:7–35.
   PubMedGoogle Scholar
• Abd-Alrazaq A, Alajlani M, Alhuwail D, et al. Artificial intelligence in the fight against COVID-19: scoping review. J Med Internet Res. 2020;22(12):e20756.
   PubMed Web of Science ®Google Scholar
• Comito C, Pizzuti C. Artificial intelligence for forecasting and diagnosing COVID-19 pandemic: a focused review. Artif Intell Med. 2022;128:102286.
   PubMed Web of Science ®Google Scholar
• Coca A, Kreutz R, Manolis AJ, et al. A practical approach to switch from a multiple pill therapeutic strategy to a polypill-based strategy for cardiovascular prevention in patients with hypertension. J Hypertens. 2020;38(10):1890–1898.
   PubMed Web of Science ®Google Scholar
• Lieneck C, Herzog B, Krips R. Analysis of facilitators and barriers to the delivery of routine care during the COVID-19 global pandemic: a systematic review. Healthcare. 2021;9(5):528.
   Web of Science ®Google Scholar
• Capodilupo ER, Miller DJ. Changes in health promoting behavior during COVID-19 physical distancing: utilizing wearable technology to examine trends in sleep, activity, and cardiovascular indicators of health. PLoS One. 2021;16(8):e0256063.
   PubMed Web of Science ®Google Scholar
• Castellano JM, Pocock SJ, Bhatt DL, et al. Polypill strategy in secondary cardiovascular prevention. N Engl J Med. 2022;387(11):967–977.
   PubMed Web of Science ®Google Scholar
• Keppel G, Cole AM, Ramsbottom M, et al. Early response of primary care practices to COVID-19 pandemic. J Prim Care Community Health. 2022;13:21501319221085374.
   Web of Science ®Google Scholar
• Pereira AM, Almeida R, Amaral R, et al. What do physicians think about the use of telemedicine to recruit and assess participants in mHealth-related clinical studies as a consequence of the COVID-19 pandemic? Telemed J E Health. 2022;28(9):1386–1392.
   PubMed Web of Science ®Google Scholar
• Task Force for the Management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022;43:1059–1103.
   PubMed Web of Science ®Google Scholar
• Khemraj RR, Solano C, Patel NM, et al. Impact of social disparities on cardiovascular disease and COVID-19 outcomes: barriers to care and preventive interventions. J Cardiopulm Rehabil Prev. 2022;42(2):84–89.
   PubMed Web of Science ®Google Scholar
• Kalwani NM, Osmanlliu E, Parameswaran V, et al. Changes in telemedicine use and ambulatory visit volumes at a multispecialty cardiovascular center during the COVID-19 pandemic. J Telemed Telecare. 2022;1357633X211073428.
   PubMed Web of Science ®Google Scholar
• Myronuk L. Effect of telemedicine via videoconference on provider fatigue and empathy: implications for the quadruple aim. Healthc Manage Forum. 2022;35(3):174–178.
   PubMedGoogle Scholar
• Hassan TA, Sáenz JE, Ducinskiene D, et al. New strategies to improve patient adherence to medications for noncommunicable diseases during and after the COVID-19 era identified via a literature review. J Multidiscip Healthc. 2021;14:2453–2465.
   PubMed Web of Science ®Google Scholar
• Midão L, Almada M, Carrilho J, et al. Pharmacological adherence behavior changes during COVID-19 outbreak in a Portugal patient cohort. Int J Environ Res Public Health. 2022;19(3):1135.
   PubMed Web of Science ®Google Scholar
• Thom S, Poulter N, Field J, et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. J Am Med Assoc. 2013;310(9):918–929.
   PubMed Web of Science ®Google Scholar
• Selak V, Elley CR, Bullen C, et al. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care. Br Med J. 2014;348:g3318.
   PubMed Web of Science ®Google Scholar
• Patel A, Cass A, Peiris D, et al. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk. Eur J Prev Cardiol. 2015;22(7):920–930.
   PubMed Web of Science ®Google Scholar
• Castellano JM, Verdejo J, Ocampo S, et al. Clinical effectiveness of the cardiovascular polypill in a Real-Life setting in patients with cardiovascular risk: the SORS study. Arch Med Res. 2019;50(1):31–40.
   PubMed Web of Science ®Google Scholar
• González-Juanatey JR, Tamargo J, Torres F, et al. Estudio farmacodinámico del policomprimido cardiovascular: ¿existe algún tipo de interacción entre los monocomponentes? Rev Esp Cardiol. 2021;74(1):51–58.
   PubMed Web of Science ®Google Scholar
• González-Juanatey JR, Cordero A, Castellano JM, et al. The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: the NEPTUNO study. Int J Cardiol. 2022;361:116–123.
   PubMed Web of Science ®Google Scholar